vTv Therapeutics Inc. VTVT
30.21
(0.52)
(1.69%)
as of 25 Sep
- Market cap
- $121.5M
- P/E
- 0.0×
Follow VTVT
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | 77.00 | — | 27.43 | 15.56 | 13.66 | 18.63 | 2.65 | 201.83 | 75.75 |
P/FCF ratio |
— | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | (16.52) | — | (8.08) | (9.71) | (39.64) | (8.76) | (5.62) | (9.28) | (4.20) |
P/B ratio |
— | 5.57 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
— | 5.57 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
— | 41.71 | — | 21.61 | 12.34 | 12.87 | 18.29 | 3.03 | 213.50 | 11.96 |
EV/EBITDA |
— | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | (1.71) | — | (2.73) | (2.56) | (4.59) | (2.20) | (1.40) | (1.39) | (0.16) |
EV/FCF |
— | (1.70) | — | (2.72) | (2.59) | (4.65) | (2.22) | (1.40) | (1.39) | (0.16) |
Quick Ratio |
13.39 | 7.08 | 0.90 | 1.60 | 1.59 | 0.92 | 0.13 | 0.09 | 0.74 | 4.50 |
Current Ratio |
13.54 | 7.34 | 1.00 | 3.52 | 1.84 | 1.13 | 0.21 | 0.18 | 0.76 | 4.56 |
Net Debt/EBITDA |
2.71 | 1.53 | 0.37 | 0.53 | 0.60 | 0.45 | 0.05 | (0.25) | (0.07) | 0.74 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 1.02% | 1.93% | 4.57% | 8.97% | 73.96% | 54.86% | 20.29% |
Debt/Equity |
0.00 | 0.00 | 0.00 | (0.03) | (0.05) | (0.01) | (0.02) | (0.08) | (0.10) | (0.12) |
Asset Turnover |
0.00 | 0.04 | 0.00 | 0.07 | 0.20 | 0.53 | 0.31 | 0.68 | 0.01 | 0.01 |
Operating CF/Net income |
0.94 | 1.37 | 0.94 | 0.84 | 1.49 | 2.12 | 1.76 | 3.10 | 2.76 | 2.95 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (0.23) | 0.00 | 0.00 | 0.42 | 0.01 | (0.02) | (0.20) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (68.52%) | 355.76% | 114.34% | 187.15% | 28.91% | 13.16% | 19.78% | 7.40% | 13.34% | 19.36% | |
| (42.09%) | (74.92%) | (91.51%) | (65.28%) | (64.51%) | (70.66%) | (146.36%) | (47.43%) | (39.18%) | (22.40%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(32.40%) | (56.04%) | (13,064.52%) | (97.81%) | (175.48%) | (713.00%) | 129.38% | 56.56% | 256.91% | (39.76%) |
Average Days of Receivables |
— | 22.25 | 0.00 | 31.29 | 5.19 | 8.99 | 0.66 | 0.00 | 10,034.36 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 1,135.30% | 0.00% | 612.34% | 332.68% | 171.73% | 547.00% | 185.26% | 13,621.99% | 7,215.77% |
Selling, General and Administrative Expense of Revenue |
0.00% | 1,342.28% | 0.00% | 604.61% | 308.19% | 113.05% | 308.86% | 74.18% | 3,894.50% | 1,562.46% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 271.09% | 0.00% | 63.03% | 58.83% | 15.73% | 54.92% | 21.52% | 1,252.58% | 416.56% |
Graham Net Nets |
— | 0.18 | — | (0.30) | (0.31) | (1.00) | (1.08) | (2.67) | (2.70) | (1.94) |
Graham Number |
— | 0.00 | — | 35.48 | 35.09 | 107.81 | 190.06 | 429.54 | 967.96 | 767.98 |
Earnings Yield |
— | (24.69%) | — | (34.53%) | (22.11%) | (10.22%) | (36.47%) | (29.06%) | (27.56%) | (34.19%) |
Free Cash Flow Yield |
— | (31.86%) | — | (28.98%) | (30.60%) | (20.26%) | (44.24%) | (81.39%) | (75.91%) | (100.63%) |
Revenue per Share |
0.00 | 0.18 | 0.00 | 1.05 | 2.56 | 5.44 | 3.65 | 39.96 | 1.20 | 2.66 |
Operating CF per Share |
(3.00) | (4.39) | (9.15) | (8.35) | (12.33) | (15.27) | (30.39) | (86.30) | (183.90) | (201.96) |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | 0.00 | 0.00 | 0.32 | 0.02 | (0.10) | (0.35) |
Free Cash Flow per Share |
(3.00) | (4.39) | (9.15) | (8.36) | (12.33) | (15.27) | (30.08) | (86.28) | (184.01) | (202.31) |
Cash per Share |
10.56 | 6.37 | 4.53 | 6.32 | 8.57 | 4.88 | 2.35 | 5.41 | 49.20 | 215.77 |
Shareholders Equity per Share |
7.65 | 2.48 | (11.84) | (5.59) | (6.22) | (67.97) | (64.73) | (266.24) | (623.39) | (381.00) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
7.65 | 2.48 | (11.84) | (5.59) | (6.22) | (67.97) | (64.73) | (266.24) | (623.39) | (381.00) |
Free Cash Flow |
(25.25) | (25.31) | (19.08) | (16.04) | (19.31) | (18.00) | (22.78) | (26.85) | (44.58) | (48.29) |
Working Capital |
83.25 | 32.92 | 0.04 | 19.39 | 7.12 | 0.83 | (10.54) | (15.36) | (6.57) | 40.68 |
Capital Expenditures |
— | — | — | (0.02) | — | — | 0.24 | 0.01 | (0.02) | (0.08) |
Net Current Asset Value |
64.43 | 14.15 | (25.04) | (16.88) | (19.59) | (87.68) | (55.45) | (87.94) | (158.60) | (93.32) |
EV/EBIT |
— | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | 0.00 | — | 0.01 | 0.00 | 0.00 | (0.09) | 0.00 | 0.09 | 0.13 |
Net Profit Margin |
0.00% | (1,815.34%) | 0.00% | (949.65%) | (324.27%) | (132.51%) | (471.92%) | (69.57%) | (5,547.77%) | (2,579.18%) |
Price to Operating Income |
— | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.00 | 3.18 | 0.77 | 0.44 | 0.32 | 1.29 | 1.24 | 17.60 | 4.33 | 0.94 |
Cash ROIC |
(16.47%) | (49.63%) | 126.02% | (941.36%) | (470.03%) | 24.93% | 50.58% | 35.98% | 36.22% | 171.42% |
Accounts Receivable Turnover |
— | 12.40 | 0.00 | 17.55 | 37.26 | 78.70 | 0.69 | 0.00 | 0.07 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | — | — | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | — | — | — | — | — |
Average Receivables |
— | 0.08 | 0.14 | 0.12 | 0.11 | 0.08 | 4.00 | — | 4.03 | — |
Average Payables |
5.79 | 7.63 | 8.78 | 7.67 | 7.07 | 6.59 | 7.39 | 10.80 | 12.66 | 9.46 |
Average Assets |
64.08 | 24.64 | 22.13 | 29.36 | 20.13 | 12.03 | 8.91 | 18.24 | 41.21 | 73.01 |
Average Common Equity |
39.37 | (5.19) | (17.71) | (10.24) | (44.92) | (64.56) | (65.94) | (116.95) | (121.00) | (84.46) |
Columns are period end dates